Sign up Australia
Proactive Investors - Run By Investors For Investors

Sigma Healthcare's continued challenges further impact revenue projections

Sigma shares have fallen 3.8% to A$0.895 in the first minutes of trade.
Doctor and patient
Profits will be lower

Sigma Healthcare Ltd (ASX:SIG) shares have already been battered in the past couple of months, as the company outlined sales challenges.

Sigma closed yesterday at A$0.93, an improvement from the recent 12-month low of A$0.73, but well down from the high of A$1.53 late in 2016 before the problems were known to the market.

The company has today outlined further challenging general industry conditions.

Sigma now anticipates that 1H18 underlying EBIT will be around A$44mln, with FY2018 underlying EBIT expected to be around A$90mln.

This compares to current market consensus for FY18 of circa A$95mln underlying EBIT.

Mark Hooper, CEO and managing director, commented: "Sigma delivered above guidance growth in FY17 and remains confident that our business strategy and increased investment in infrastructure will deliver growth and efficiency improvements beyond the current year."





Register here to be notified of future . Company articles
View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

White board with marketing ideas
March 14 2017
There was a bit of a wobble in the run-up to the Brexit vote and shortly after it, but the group's 'buy, build & grow' strategy is taking shape
1505911280_social-media.jpg
September 20 2017
The Cello Health unit led the way as it grew organically and via the acquisition
Laptop screen with graphs
August 04 2017
Total revenues for the six months to 30 June grew by 5%, with Ebiquity adding it remains confident in hitting its operating profits and earnings targets for the rest of the year

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use